Skip to main content

Table 3 Swedish universities Scales of Personality (SSP) raw scores (mean [standard deviation]) and 95% confidence interval (CI) of the difference between baseline and follow-up in patients with psychotic illness and non-psychotic controls

From: Correction to: Stability of personality traits over a five-year period in Swedish patients with schizophrenia spectrum disorder and nonpsychotic individuals: a study using the Swedish universities scales of personality

   N Somatic Trait Anxiety Psychic Trait Anxiety Stress Susceptibility
Baseline Follow-up CI Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 36 2.08 (0.48) 2.13 (0.53) −0.25 – 0.15 2.45 (0.62) 2.36 (0.61) −0.09 – 0.27 2.46 (0.55) 2.47 (0.53) −0.19 – 0.16
Control 76 1.58 (0.46) 1.55 (0.45) −0.06 – 0.12 1.66 (0.50) 1.48 (0.39) 0.11–0.26 1.87 (0.47) 1.82 (0.44) −0.05 – 0.14
ALL Men 75 1.68 (0.48) 1.71 (0.56) −0.14 – 0.08 1.92 (0.68) 1.79 (0.66) 0.04–0.22 2.06 (0.61) 2.02 (0.58) −0.06 – 0.14
Women 37 1.85 (0.58) 1.78 (0.53) −0.08 – 0.21 1.90 (0.60) 1.70 (0.55) 0.07–0.34 2.04 (0.46) 2.05 (0.53) −0.17 – 0.16
PATIENT Men 28 2.05 (0.39) 2.19 (0.51) −0.39 – 0.09 2.47 (0.60) 2.43 (0.52) −0.17 – 0.24 2.48 (0.60) 2.52 (0.46) −0.24 – 0.17
Women 8 2.21 (0.71) 1.93 (0.57) 0.02–0.55 2.38 (0.71) 2.09 (0.84) −0.17 – 0.74 2.36 (0.38) 2.30 (0.76) −0.40 – 0.51
CONTROL Men 47 1.47 (0.39) 1.43 (0.36) −0.06 – 0.14 1.60 (0.49) 1.41 (0.37) 0.10–0.28 1.81 (0.47) 1.72 (0.41) −0.02 – 0.20
Women 29 1.75 (0.51) 1.74 (0.52) −0.16 – 0.18 1.77 (0.51) 1.59 (0.40) 0.04–0.33 1.96 (0.45) 1.98 (0.44) −0.21 – 0.17
   Lack of Assertiveness Impulsiveness Adventure Seeking
Baseline Follow-up CI Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 2.50 (0.64) 2.43 (0.62) −0.13 – 0.28 2.33 (0.52) 2.25 (0.51) −0.07 – 0.23 2.50 (0.58) 2.38 (0.61) −0.04 – 0.29
Control 1.91 (0.40) 1.87 (0.43) −0.04 – 0.11 2.30 (0.46) 2.19 (0.47) 0.02–0.20 2.53 (0.52) 2.39 (0.51) 0.07–0.22
ALL Men 2.12 (0.58) 2.07 (0.61) −0.06 – 0.16 2.23 (0.47) 2.15 (0.47) −0.01 – 0.17 2.57 (0.58) 2.42 (0.56) 0.06–0.25
Women 2.06 (0.54) 2.02 (0.44) − 0.07 – 0.15 2.48 (0.45) 2.34 (0.49) 0.01–0.28 2.42 (0.43) 2.33 (0.50) − 0.01 – 0.21
PATIENT Men 2.55 (0.59) 2.48 (0.63) −0.18 – 0.33 2.28 (0.51) 2.21 (0.52) −0.12 – 0.24 2.52 (0.62) 2.34 (0.65) −0.02 – 0.38
Women 2.34 (0.83) 2.27 (0.59) −0.21 – 0.35 2.52 (0.51) 2.38 (0.48) −0.22 – 0.49 2.46 (0.39) 2.54 (0.46) −0.33 – 0.19
CONTROL Men 1.86 (0.40) 1.83 (0.45) −0.06 – 0.13 2.19 (0.44) 2.11 (0.44) −0.02 – 0.20 2.61 (0.55) 2.47 (0.51) 0.04–0.24
Women 1.99 (0.41) 1.95 (0.37) −0.09 – 0.16 2.47 (0.44) 2.33 (0.50) −0.00 – 0.30 2.41 (0.44) 2.27 (0.50) 0.02–0.27
   Detachment Social Desirability Embitterment
Baseline Follow-up CI Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 2.33 (0.63) 2.31 (0.52) −0.14 – 0.17 2.77 (0.53) 2.83 (0.45) −0.24 – 0.13 2.23 (0.50) 2.22 (0.55) −0.15 – 0.17
Control 1.90 (0.43) 1.85 (0.43) −0.02 – 0.12 2.83 (0.37) 2.92 (0.35) −0.15 - -0.03 1.60 (0.41) 1.47 (0.40) 0.05–0.20
ALL Men 2.16 (0.54) 2.13 (0.49) −0.05 – 0.12 2.80 (0.43) 2.88 (0.39) −0.16 – 0.00 1.82 (0.52) 1.72 (0.59) 0.01–0.20
Women 1.78 (0.45) 1.74 (0.42) −0.09 – 0.18 2.82 (0.42) 2.90 (0.38) −0.21 – 0.06 1.75 (0.56) 1.69 (0.54) −0.06 – 0.18
PATIENT Men 2.41 (0.65) 2.39 (0.50) −0.14 – 0.20 2.82 (0.56) 2.80 (0.46) −0.18 – 0.21 2.23 (0.44) 2.23 (0.57) −0.20 – 0.20
Women 2.04 (0.52) 2.05 (0.53) −0.51 – 0.48 2.61 (0.42) 2.91 (0.44) −0.87 – 0.26 2.23 (0.69) 2.17 (0.51) −0.22 – 0.34
CONTROL Men 2.02 (0.41) 1.97 (0.42) −0.05 – 0.13 2.79 (0.34) 2.93 (0.34) −0.21 - − 0.07 1.58 (0.39) 1.42 (0.34) 0.08–0.25
Women 1.71 (0.41) 1.65 (0.35) -0.07 – 0.20 2.88 (0.41) 2.90 (0.36) −0.12 – 0.09 1.62 (0.45) 1.56 (0.47) −0.08 – 0.20
   Trait Irritability Mistrust   
Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 2.35 (0.57) 2.13 (0.57) 0.03–0.40 2.26 (0.58) 2.26 (0.52) − 0.13 – 0.15   
Control 2.21 (0.48) 2.03 (0.49) 0.09–0.26 1.75 (0.50) 1.60 (0.47) 0.06–0.24   
ALL Men 2.26 (0.49) 2.04 (0.53) 0.12–0.31 1.97 (0.56) 1.86 (0.57) 0.02–0.21   
Women 2.24 (0.55) 2.11 (0.50) −0.03 – 0.29 1.81 (0.59) 1.72 (0.58) −0.03 – 0.21   
PATIENT Men 2.36 (0.56) 2.16 (0.53) 0.01–0.38 2.28 (0.58) 2.25 (0.53) −0.14 – 0.21   
Women 2.32 (0.66) 2.04 (0.74) −0.37 – 0.94 2.20 (0.62) 2.29 (0.55) −0.24 – 0.07   
CONTROL Men 2.20 (0.45) 1.97 (0.51) 0.11–0.34 1.79 (0.47) 1.62 (0.47) 0.05–0.28   
Women 2.22 (0.53) 2.13 (0.43) −0.05 – 0.22 1.70 (0.54) 1.56 (0.49) −0.01 -0.29   
   Verbal Trait Aggression Physical Trait Aggression   
Baseline Follow-up CI Baseline Follow-up CI
ALL Patient 2.01 (0.64) 2.00 (0.55) −0.19 – 0.20 1.71 (0.57) 1.84 (0.60) −0.31 – 0.07   
Control 2.15 (0.47) 1.96 (0.46) 0.10–0.28 1.93 (0.57) 1.67 (0.54) 0.17–0.35   
ALL Men 2.12 (0.53) 2.02 (0.52) −0.01 – 0.21 1.92 (0.60) 1.81 (0.59) 0.00–0.23   
Women 2.07 (0.55) 1.88 (0.43) 0.04–0.33 1.73 (0.53) 1.55 (0.46) 0.01–0.33   
PATIENT Men 2.03 (0.62) 2.07 (0.58) −0.26 – 0.18 1.76 (0.59) 1.86 (0.66) −0.33 – 0.13   
Women 1.95 (0.74) 1.79 (0.38) −0.37 – 0.69 1.54 (0.47) 1.74 (0.39) −0.57 – 0.16   
CONTROL Men 2.18 (0.46) 2.00 (0.48) 0.07–0.31 2.02 (0.58) 1.78 (0.55) 0.14–0.35   
Women 2.10 (0.50) 1.91 (0.44) 0.04–0.34 1.78 (0.54) 1.50 (0.47) 0.11–0.44